Copperleaf Capital LLC Makes New Investment in Medtronic PLC $MDT

Copperleaf Capital LLC bought a new stake in shares of Medtronic PLC (NYSE:MDT) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 8,019 shares of the medical technology company’s stock, valued at approximately $764,000.

Other hedge funds have also made changes to their positions in the company. Global Trust Asset Management LLC lifted its stake in Medtronic by 18.8% in the third quarter. Global Trust Asset Management LLC now owns 3,463 shares of the medical technology company’s stock valued at $330,000 after buying an additional 548 shares during the last quarter. Wilmington Savings Fund Society FSB increased its holdings in shares of Medtronic by 2.0% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 104,576 shares of the medical technology company’s stock worth $9,960,000 after acquiring an additional 2,088 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its position in Medtronic by 0.8% in the 3rd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 190,379 shares of the medical technology company’s stock valued at $18,132,000 after purchasing an additional 1,600 shares during the last quarter. True Vision MN LLC bought a new position in Medtronic in the 3rd quarter worth about $209,000. Finally, BCS Private Wealth Management Inc. increased its stake in shares of Medtronic by 3.0% in the third quarter. BCS Private Wealth Management Inc. now owns 8,280 shares of the medical technology company’s stock valued at $794,000 after purchasing an additional 240 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently weighed in on MDT. Piper Sandler reaffirmed a “neutral” rating on shares of Medtronic in a report on Monday, January 5th. Jefferies Financial Group reiterated a “hold” rating and set a $110.00 price objective on shares of Medtronic in a research report on Wednesday, November 19th. Wall Street Zen lowered Medtronic from a “buy” rating to a “hold” rating in a report on Saturday, January 3rd. The Goldman Sachs Group set a $111.00 price target on Medtronic and gave the company a “neutral” rating in a report on Wednesday, November 19th. Finally, Stifel Nicolaus upped their price target on Medtronic from $90.00 to $105.00 and gave the company a “hold” rating in a research report on Thursday, October 9th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $110.28.

Medtronic Stock Performance

Shares of NYSE MDT opened at $98.88 on Friday. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.42 and a quick ratio of 1.80. Medtronic PLC has a one year low of $79.55 and a one year high of $106.33. The business’s 50-day moving average price is $98.90 and its two-hundred day moving average price is $94.77. The company has a market capitalization of $126.77 billion, a P/E ratio of 26.65, a price-to-earnings-growth ratio of 2.60 and a beta of 0.71.

Medtronic (NYSE:MDT) last issued its quarterly earnings data on Tuesday, November 18th. The medical technology company reported $1.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.31 by $0.05. Medtronic had a net margin of 13.71% and a return on equity of 14.86%. The firm had revenue of $8.96 billion during the quarter, compared to analysts’ expectations of $8.86 billion. During the same period in the prior year, the company posted $1.26 earnings per share. Medtronic’s revenue for the quarter was up 6.6% on a year-over-year basis. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. Analysts anticipate that Medtronic PLC will post 5.46 earnings per share for the current fiscal year.

Medtronic Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Friday, December 26th will be paid a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Friday, December 26th. Medtronic’s dividend payout ratio (DPR) is presently 76.55%.

Medtronic Company Profile

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).